AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
10.04
0.00 (0.00%)
Jan 7, 2025, 4:00 PM EST - Market closed

AdaptHealth Statistics

Total Valuation

AdaptHealth has a market cap or net worth of $1.32 billion. The enterprise value is $3.40 billion.

Market Cap 1.32B
Enterprise Value 3.40B

Important Dates

The next estimated earnings date is Tuesday, February 25, 2025, before market open.

Earnings Date Feb 25, 2025
Ex-Dividend Date n/a

Share Statistics

AdaptHealth has 131.62 million shares outstanding. The number of shares has decreased by -0.81% in one year.

Current Share Class 131.62M
Shares Outstanding 131.62M
Shares Change (YoY) -0.81%
Shares Change (QoQ) +0.37%
Owned by Insiders (%) 11.25%
Owned by Institutions (%) 77.86%
Float 78.30M

Valuation Ratios

PE Ratio n/a
Forward PE 10.45
PS Ratio 0.41
Forward PS 0.39
PB Ratio 0.87
P/TBV Ratio n/a
P/FCF Ratio 5.76
P/OCF Ratio 2.42
PEG Ratio 1.44
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.08, with an EV/FCF ratio of 14.82.

EV / Earnings n/a
EV / Sales 1.04
EV / EBITDA 5.08
EV / EBIT 11.24
EV / FCF 14.82

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 1.43.

Current Ratio 1.24
Quick Ratio 0.91
Debt / Equity 1.43
Debt / EBITDA 2.98
Debt / FCF 9.50
Interest Coverage 2.32

Financial Efficiency

Return on equity (ROE) is -12.88% and return on invested capital (ROIC) is 4.88%.

Return on Equity (ROE) -12.88%
Return on Assets (ROA) 4.11%
Return on Capital (ROIC) 4.88%
Revenue Per Employee $304,913
Profits Per Employee -$20,351
Employee Count 10,700
Asset Turnover 0.71
Inventory Turnover 21.22

Taxes

In the past 12 months, AdaptHealth has paid $3.82 million in taxes.

Income Tax 3.82M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +38.48% in the last 52 weeks. The beta is 1.09, so AdaptHealth's price volatility has been similar to the market average.

Beta (5Y) 1.09
52-Week Price Change +38.48%
50-Day Moving Average 9.94
200-Day Moving Average 10.32
Relative Strength Index (RSI) 54.30
Average Volume (20 Days) 1,664,763

Short Selling Information

The latest short interest is 9.67 million, so 7.35% of the outstanding shares have been sold short.

Short Interest 9.67M
Short Previous Month 10.12M
Short % of Shares Out 7.35%
Short % of Float 12.36%
Short Ratio (days to cover) 11.06

Income Statement

In the last 12 months, AdaptHealth had revenue of $3.26 billion and -$217.76 million in losses. Loss per share was -$1.65.

Revenue 3.26B
Gross Profit 611.45M
Operating Income 302.22M
Pretax Income -730.11M
Net Income -217.76M
EBITDA 669.38M
EBIT 302.22M
Loss Per Share -$1.65
Full Income Statement

Balance Sheet

The company has $102.30 million in cash and $2.18 billion in debt, giving a net cash position of -$2.08 billion or -$15.78 per share.

Cash & Cash Equivalents 102.30M
Total Debt 2.18B
Net Cash -2.08B
Net Cash Per Share -$15.78
Equity (Book Value) 1.52B
Book Value Per Share 11.52
Working Capital 130.77M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $546.69 million and capital expenditures -$317.37 million, giving a free cash flow of $229.32 million.

Operating Cash Flow 546.69M
Capital Expenditures -317.37M
Free Cash Flow 229.32M
FCF Per Share $1.74
Full Cash Flow Statement

Margins

Gross margin is 18.74%, with operating and profit margins of 9.26% and -6.57%.

Gross Margin 18.74%
Operating Margin 9.26%
Pretax Margin -6.33%
Profit Margin -6.57%
EBITDA Margin 20.52%
EBIT Margin 9.26%
FCF Margin 7.03%

Dividends & Yields

AdaptHealth does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.81%
Shareholder Yield 0.81%
Earnings Yield -16.48%
FCF Yield 17.35%
Dividend Details

Analyst Forecast

The average price target for AdaptHealth is $12.40, which is 23.51% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.40
Price Target Difference 23.51%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AdaptHealth has an Altman Z-Score of 1.05 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.05
Piotroski F-Score 6